Elevated levels of interleukin 17A and kynurenine in candidemic patients, compared with levels in noncandidemic patients in the intensive care unit and those in healthy controls

Journal of Infectious Diseases

Volumn 211, Issue 3, 2015, Pages 445-451

  Krause, Robert ^a   Zollner Schwetz, Ines ^a   Salzer, Helmut J F ^a,f   Valentin, Thomas ^a   Rabensteiner, Jasmin ^a   Prüller, Florian ^b   Raggam, Reinhard ^b   Meinitzer, Andreas ^b   Prattes, Jürgen ^a   Rinner, Beate ^c   Strohmaier, Heimo ^c   Quehenberger, Franz ^d   Strunk, Dirk ^e   Heidrich, Katharina ^a   Buzina, Walter ^a   Hoenigl, Martin ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Chemical Laboratory Diagnostics   (Austria)

^c Center for Medical Research   (Austria)

^d Institute for Medical Informatics Statistics and Documentation   (Austria)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

candida; interleukins; kynurenine

Indexed keywords

ANTIBIOTIC AGENT; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; DECTIN 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; KYNURENINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TRYPTOPHAN; IL17A PROTEIN, HUMAN; LECTIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD LEVEL; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; INTENSIVE CARE UNIT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PICHIA KUDRIAVZEVII; PNEUMONIA; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INTUBATION; TIME; VERY ELDERLY; ADOLESCENT; CANDIDIASIS; CASE CONTROL STUDY; CLINICAL TRIAL; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERFERON-GAMMA; INTERLEUKIN-17; KYNURENINE; LECTINS, C-TYPE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRYPTOPHAN; YOUNG ADULT;

EID: 84922572903     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu468     Document Type: Article

References (18)

1. Hernandez-Santoz N, Gaffen SL. Th17 cells in immunity to Candida albicans. Cell Host Microbe 2012; 11:425-35.
2. Cheng SC, Joosten LAB, Kullberg BJ, Netea MG. Interplay between Candida albicans and the Mammalian Innate Host Defense. Infect Immun 2012; 80:1304-13.
3. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11:275.
4. Ozment-Skelton TR, de Fluiter EA, Ha T, et al. Leukocyte Dectin-1 expression is differentially regulated in fungal versus polymicrobial sepsis. Crit Care Med 2009; 37:1038-45.
5. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888-98.
6. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007; 51:1139-47.
7. Camargo JF, Husain S. Immune correlates of protection in human invasive aspergillosis. Clin Infect Dis 2014; 59:569-77.
8. Chai LY, van de Veerdonk F, Marijnissen RJ, et al. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 2010; 130:46-54.
9. Cheng SC, van de Veerdonk F, Smeekens S, et al. Candida albicans dampens host defense by downregulating IL-17 production. J Immunol 2010; 185:2450-7.
10. Gresnigt MS, Becker KL, Smeekens SP, et al. Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3. J Immunol 2013; 190:5629-39.
11. Raggam RB, Wagner J, Prüller F, et al. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome. J Intern Med 2014; 19. doi:10.1111/joim.12238.
12. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema GJ. Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol 2008; 10:2058-66.
13. Hervé C, Beyne P, Jamault H, Delacoux E. Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B Biomed Appl 1996; 675:157-61.
14. Xiao LD, Luo XB, Pi LG, Tang AG. Simultaneous determination of kynurenine and kynurenic acid concentrations in human serum by HPLC with dual wavelengths. Clin Chim Acta 2008; 395:178-80.
15. Prüller F, Wagner J, Raggam RB, et al. Automation of serum (1-3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia. Med Mycol 2014; 52:455-61.
16. De Luca A, Zelante T, D'Angelo C, et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol 2010; 3:361-73.
17. Hoenigl M, Raggam RB, Wagner J, et al. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clin Biochem 2013; 46:225-9.
18. Ozment-Skelton TR, Goldman MP, Gordon S, Brown GD, Williams DL. Prolonged reduction of leukocyte membrane-associated Dectin-1 levels following β-glucan administration. J Pharmacol Exp Ther 2006; 318:540-6.